Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sherr

Showing results (211-220 of 245) with videos related to

Pageof 25
Sort By:
Diabetes Care|September 24, 2016
Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264-270Michael R Rickels, Katrina J Ruedy, Nicole C Foster, et al.
Communications Medicine|October 4, 2023
Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic reviewLaura M Jacobsen, Jennifer L Sherr, Elizabeth Considine, et al.
Diabetes Care|December 19, 2015
Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority StudyMichael R Rickels, Katrina J Ruedy, Nicole C Foster, et al.
Diabetes Care|February 18, 2016
Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 DiabetesJennifer L Sherr, Katrina J Ruedy, Nicole C Foster, et al.
Journal of Diabetes Science and Technology|July 1, 2025
Evolution of the Artificial Pancreas: Components and Integration-CGMs, Insulin, and AP SystemsRichard M Bergenstal, Adam Heller, Marc D Breton, et al.
JAMA|February 24, 2023
Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical TrialGregory P Forlenza, Jennifer McVean, Roy W Beck, et al.
Diabetes, Obesity & Metabolism|September 20, 2024
Psychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetesSarah A MacLeish, Korey K Hood, William H Polonsky, et al.
JAMA|February 24, 2023
Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical TrialJennifer McVean, Gregory P Forlenza, Roy W Beck, et al.
Diabetes, Obesity & Metabolism|January 26, 2026
International clinical opinion on transparency, standardisation, and calibration alignment in the performance evaluation of systems for continuous glucose monitoringJohn S Pemberton, Robert C Andrews, Katharine Barnard-Kelly, et al.
Pediatric Diabetes|April 30, 2025
Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their CaregiversKorey K Hood, William H Polonsky, Sarah A MacLeish, et al.
Pageof 25

Showing results (211-220 of 245) with videos related to

Sort By:
Pageof 25
Diabetes Care|September 24, 2016
Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264-270Michael R Rickels, Katrina J Ruedy, Nicole C Foster, et al.
Communications Medicine|October 4, 2023
Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic reviewLaura M Jacobsen, Jennifer L Sherr, Elizabeth Considine, et al.
Diabetes Care|December 19, 2015
Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority StudyMichael R Rickels, Katrina J Ruedy, Nicole C Foster, et al.
Diabetes Care|February 18, 2016
Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 DiabetesJennifer L Sherr, Katrina J Ruedy, Nicole C Foster, et al.
Journal of Diabetes Science and Technology|July 1, 2025
Evolution of the Artificial Pancreas: Components and Integration-CGMs, Insulin, and AP SystemsRichard M Bergenstal, Adam Heller, Marc D Breton, et al.
JAMA|February 24, 2023
Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical TrialGregory P Forlenza, Jennifer McVean, Roy W Beck, et al.
Diabetes, Obesity & Metabolism|September 20, 2024
Psychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetesSarah A MacLeish, Korey K Hood, William H Polonsky, et al.
JAMA|February 24, 2023
Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical TrialJennifer McVean, Gregory P Forlenza, Roy W Beck, et al.
Diabetes, Obesity & Metabolism|January 26, 2026
International clinical opinion on transparency, standardisation, and calibration alignment in the performance evaluation of systems for continuous glucose monitoringJohn S Pemberton, Robert C Andrews, Katharine Barnard-Kelly, et al.
Pediatric Diabetes|April 30, 2025
Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their CaregiversKorey K Hood, William H Polonsky, Sarah A MacLeish, et al.
Pageof 25